ClinicalTrials.gg
CompletedNCT07054164Updated Jul 8, 2025

Effect of Dual-Task Aerobic Exercise on Children With Specific Learning Disorder

An interventional study of dual-task aerobic exercise and aerobic exercise in Specific Learning Disorder, sponsored by Bezmialem Vakif University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 7 Years to 14 Years. Per ClinicalTrials.gov, last updated 2025-07-08.

Sponsored by Bezmialem Vakif University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Sep 2023, registered Jun 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
7 Years to 14 Years
Sex
All
01

Study summary

The aim of the present study is to investigate the effects of dual-task aerobic exercise training on attention, balance, and quality of life in children with Specific Learning Disorder.

Read the detailed description

Specific Learning Disorder is a neurodevelopmental condition characterized by difficulties in basic academic skills such as reading, writing, language comprehension, mathematical calculations, and information processing, despite normal or above-normal intellectual capacity.

Although the primary difficulties experienced by individuals diagnosed with Specific Learning Disorder involve impairments in acquiring academic skills such as learning and performing mathematical calculations, various deficiencies have also been observed in physical domains such as balance and motor coordination.

No previous studies have been identified in the literature examining the effects of dual-task focused aerobic exercises on individuals diagnosed with Specific Learning Disorder. The investigators hypothesize that dual-task focused aerobic exercise training administered to children with Specific Learning Disorder will have positive effects on attention, balance, and quality of life.

02

Conditions studied

  • Specific Learning Disorder

Keywords

  • Specific Learning Disorder
  • Aerobic Exercise
03

In context

Specific Learning Disorder

24 studies on the registry are indexed under Specific Learning Disorder; 4 are open to participants now.

This study's enrollment of 30 is below the median of 153 across 16 interventional studies indexed under Specific Learning Disorder.

Browse Specific Learning Disorder studies →

Lead sponsor

Bezmialem Vakif University is the lead sponsor of 354 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with a specific learning disorder according to criteria
  • Being between the ages of 6-14
  • Having reading skills
  • Not having received treatment for a specific learning disorder

Exclusion criteria

Exclusion Criteria:

  • Having a chronic and serious systemic disease
  • Having a seizure-like neurological disorder
  • Having vision, speech and hearing problems
  • Not attending the individual education program regularly
  • Having any for physical exercise
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Other
    dual-task aerobic exercise group

    3 days a week, 50 minutes (10 warm-ups, 30 minutes of moderate-high intensity walking, 10 minutes of cooling down) moderate-high intensity treadmill aerobic training was provided under the supervision of a physiotherapist. In addition to aerobic training, some cognitive tasks were given to the participants during the treadmill walks.

    Other: dual-task aerobic exercise

  • Other
    aerobic exercise group

    3 days a week, 50 minutes (10 warm-ups, 30 minutes of moderate-high intensity walking, 10 minutes of cooling down) moderate-high intensity treadmill aerobic training was provided under the supervision of a physiotherapist.

    Other: aerobic exercise

  • No intervention
    control group

    no intervention

Interventions

  • Otherdual-task aerobic exercise

    In addition to aerobic training during treadmill walks, participants were given some cognitive tasks and were asked to continue these tasks throughout the exercise.

  • Otheraerobic exercise

    Aerobic training with a treadmill at medium-high intensity, 3 days a week, for 8 weeks, accompanied by a physiotherapist

06

What researchers measure

Primary outcomes

  1. Stroop Test TBAG Form

    The Stroop Test TBAG Form is a neuropsychological test that evaluates complex attention, focused and selective attention, resistance to disruptive stimuli, cognitive inhibition, information processing speed and executive functions. Unit of Measure: Points

    Time frame: 8 weeks

Secondary outcomes

  1. Pediatric Balance Scale (PDS)

    The scale consists of 14 sections in total and each section is evaluated and scored between 0-4 points. The total score gives the PDS score. The score range of the scale is between 0-56 and higher scores indicate better balance performance.

    Time frame: 8 weeks

  2. Biodex Balance System

    The Biodex Balance System is an equipment that can be used for both objective assessment of postural balance and balance training. The device consists of a screen, a circular balance platform, arm support and a printer.

    Time frame: 8 weeks

  3. Quality of Life Inventory for Children (PedsQL)

    It is a scale used to evaluate the general quality of life of children aged 2-18; it consists of a total of 23 items that question children's physical, emotional, psychosocial and school-related problems, and each item is scored between 0-100.

    Time frame: 8 weeks

  4. Body composition measurement

    The Omron BF511 Body Composition Monitor® non-invasive body composition measurement device, which works with the 4-pole bioelectrical impedance method (determines the ratio of fat and muscle tissue in the body with a weak electric current passing through the body), was used to calculate the participants' skeletal muscle mass ratio (%), body fat ratio (%) and basal metabolic rate.

    Time frame: 8 weeks

  5. Body Weight Measurement

    Body weight will be measured using a digital scale with participants wearing light clothing and no shoes. Unit of Measure: Kilograms (kg)

    Time frame: 8 weeks

  6. Height Measurement

    Height will be measured using a stadiometer with participants standing upright without shoes, heels together, and head in the Frankfurt plane. Unit of Measure: Meters (m)

    Time frame: 8 weeks

  7. Body Mass Index (BMI)

    BMI will be calculated using the formula: weight in kilograms divided by the square of height in meters (kg/m²). Unit of Measure: Kilograms per square meter (kg/m²)

    Time frame: 8 weeks

07

Study locations

1 site
  • Bezmialem Vakıf University, Institute of Health Sciences, Department of Physiotherapy and Rehabilitation, Istanbul, TR
    Istanbul, Fatih 34093, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07054164
Responsible party
Mehmet Hakan Özdemir (Professor, Bezmialem Vakif University) — Principal investigator
First posted
Jul 8, 2025
Start date
Sep 26, 2023
Primary completion
Feb 5, 2025
Completion
Apr 7, 2025
Last update
Jul 8, 2025

Study contacts

Elif DURGUT, Assistant Professor, Ph.D.
principal investigator · Bezmialem Vakif University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion